Skip to main content
SpringerLink
Log in

Biomarkers

Novel troponin immunoassay for early ACS rule-out

  • News & Views
  • Published:

From Nature Reviews Cardiology

View current issue Sign up to alerts

The introduction of a new high-sensitivity troponin immunoassay might revolutionize the way acute coronary syndrome is diagnosed. The high analytical sensitivity of the assay enables earlier and more accurate identification of myocardial injury than with currently used methods, and also allows for the safe discharge of patients without myocardial ischaemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: The evolution of cardiac biomarkers for the diagnosis of acute coronary syndrome.

References

  1. Makam, A. N. & Nguyen, O. K. Use of cardiac biomarker testing in the emergency department. JAMA Intern. Med. 175, 67–75 (2015).

    Article  Google Scholar 

  2. Cervellin, G. & Lippi, G. Of MIs and men — a historical perspective on the diagnostics of acute myocardial infarction. Semin. Thromb. Hemost. 40, 535–543 (2014).

    Article  CAS  Google Scholar 

  3. Thygesen, K. et al. Third universal definition of myocardial infarction. Circulation 126, 2020–2035 (2012).

    Article  Google Scholar 

  4. Lippi, G. & Cervellin, G. Do we really need high-sensitivity troponin immunoassays in the emergency department? Maybe not. Clin. Chem. Lab. Med. 52, 205–212 (2014).

    CAS  Google Scholar 

  5. Shah, A. S. et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet http://dx.doi.org/10.1016/S0140-6736(15)00391-8.

  6. Reichlin, T. et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch. Intern. Med. 172, 1211–1218 (2012).

    Article  Google Scholar 

  7. Druey, S. et al. Early rule-out and rule-in of myocardial infarction using sensitive cardiac troponin I. Int. J. Cardiol. 195, 163–170 (2015).

    Article  Google Scholar 

  8. Lippi, G. & Cervellin, G. High-sensitivity troponin T is more susceptible than high-sensitivity troponin I to impaired renal function. Am. J. Cardiol. 112, 1985 (2013).

    Article  CAS  Google Scholar 

  9. Carro, A. & Kaski, J. C. Myocardial infarction in the elderly. Aging Dis. 2, 116–137 (2011).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Clinical Biochemistry, University of Verona, P.le Ludovico Scuro 10, Verona, 37134, Italy

    Giuseppe Lippi

Authors
  1. Giuseppe Lippi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe Lippi.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lippi, G. Novel troponin immunoassay for early ACS rule-out. Nat Rev Cardiol 13, 9–10 (2016). https://doi.org/10.1038/nrcardio.2015.174

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2015.174

  • Springer Nature Limited

This article is cited by

Search

Navigation